Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes
del Pozo-Cruz, Borja Alfonso-Rosa, Rosa M. del Pozo-Cruz, Jesus Sanudo Corrales, Borja Rogers, Michael E.
del Pozo-Cruz, Borja
Alfonso-Rosa, Rosa M.
del Pozo-Cruz, Jesus
Sanudo Corrales, Borja
Rogers, Michael E.
Authors
del Pozo-Cruz, Borja
Alfonso-Rosa, Rosa M.
del Pozo-Cruz, Jesus
Sanudo Corrales, Borja
Rogers, Michael E.
Alfonso-Rosa, Rosa M.
del Pozo-Cruz, Jesus
Sanudo Corrales, Borja
Rogers, Michael E.
Other Names
Location
Time Period
Advisors
Original Date
Digitization Date
Issue Date
2014-01
Type
Article
Genre
Keywords
Glycemic control,Diabetic patients,Vibration therapy,Exercise therapy,Prevention therapy
Subjects (LCSH)
Citation
del Pozo-Cruz, Borja; Alfonso-Rosa, Rosa M.; del Pozo-Cruz, Jesus; Sanudo, Borja; Rogers, Michael E. 2014. Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes. Maturitas, vol. 77:no. 1:ppg. 52–58
Abstract
Objective: To test the feasibility, safety and effectiveness of a 12-wk whole body vibration (WBV) intervention on glycemic control, lipid-related cardiovascular risk factors and functional capacity among type 2 diabetes mellitus (T2DM) patients in a primary care context.
Methods: Fifty non-insulin dependent T2DM patients were randomized 1:1 to an intervention group that, in addition to standard care, received a 12-wk WBV intervention, and a control group receiving only standard care (from February 2012 through May 2012). Outcomes, including glycated hemoglobin (HbA1c), fasting blood glucose, lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides, lipoproteins, LDL/HDL and atherogenic index) and functional capacity were measured at baseline and after the 12-wk intervention.
Results: After intervention, there was a reduction in HbA1c and fasting blood glucose when compared to the control group, with a mean difference in change scores between groups of -0.55% (95% CI -0.15 to -0.76) and -33.95 mm/dl (95% CI -51.38 to -3.47), respectively. Similarly, most lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides and atherogenic index) were also reduced (p < 0.05).
Conclusion:A 1 2-wk WBV intervention in a primary care context is feasible, safe and effective in improving glycemic profile, lipid-related cardiovascular risk factors and functional capacity among T2DM patients.
Table of Contents
Description
Click on the DOI link to access the article (may not be free).
Publisher
Elsevier Ireland Ltd
Journal
Book Title
Series
Maturitas;v.77:no.1
Digital Collection
Finding Aid URL
Use and Reproduction
Archival Collection
PubMed ID
DOI
ISSN
0378-5122